Imperial COVID-19 testing facilities


As the COVID-19 pandemic struck, additional facilities were required to ramp up the diagnostic testing capacity for the UK.



The Testing Alliance, set up by life sciences cluster MedCity, brought together world-leading universities, healthcare institutes, industry and pathology service providers to help increase COVID-19 testing capacity by 20,500 per day.

Imperial’s contribution was launched at St Mary’s Campus and includes the UKAS accredited Molecular Diagnostic Unit (MDU), led by Professor Myra McClure, and Professor Paul Freemont’s existing high-throughput robotic platform for RNA extraction.

This expanded facility created over fifty new positions, and joined Health Service Laboratories in partnership with UCL, King’s Health Partners, and Queen Mary University of London to form part of the Department of Health and Social Care’s partnership with MedCity’s London Testing Alliance.

“Since the beginning of the pandemic, colleagues throughout Imperial have been doing all they can to make the world safer from COVID-19. I am delighted that, thanks to MedCity, Imperial has been able to come together with our peer institutions in London to help meet the critical need for increased COVID-19 testing capacity.” Professor Alice Gast, Imperial President 

Professor Paul Freemont had already re-purposed the high-throughput robotic platform to help NHS diagnostic labs avoid bottlenecks caused by increased demand­­ for reagents. The platform is reagent-agnostic, providing flexibility to respond to supply disruptions, is highly scalable, and does not compete for access to commercial kits.

“We recognised early on that we needed to work shoulder to shoulder with our colleagues in the NHS to ensure we could get them something that was workable in their labs.” Professor Paul Freemont

Related news stories:

Robotic testing platform helps to scale up COVID-19 testing capacity

MedCity-led university Testing Alliance to offer 20,500 extra daily COVID-19 tests

Imperial part of London Alliance offering 20,500 more COVID tests a day by March

Imperial’s new COVID-19 testing lab goes live


Capacity and capability building, large-scale testing and co-branding initiatives

Imperial’s COVID-19 testing facility is supported by project management professionals from the Imperial Projects team. To discuss similar large-scale projects, please feel free to contact us.


Share post:


Related case studies


Meta study-environmental impact of diamond mining

Meta study-environmental impact of diamond mining

Skydiamonds commissioned a review of academic, industrial and grey literature on diamond production methods to provide them with a better understanding of the environmental impacts. read more

Hepatitis C genotype and drug resistance testing

Hepatitis C genotype and drug resistance testing

Genotype and resistance testing for new direct-acting antiviral (DAA) drugs designed to treat Hepatitis C virus (HCV). read more

Building a low carbon economy with ICT

Building a low carbon economy with ICT

Our consultants shared their expertise in economics to help Microsoft explore how ICT can play an enabling role in low carbon economies to reduce CO2 emissions. read more